NIH-funded research P01 program project

Understanding how epigenetic changes affect neuroendocrine cancers

Official title: Administrative Core

Funded at Dana-Farber Cancer Inst · NIH-11016328 · Data updated 2026-11-12

This study is all about helping researchers work together better to understand how certain cancers, like prostate and lung cancer, are affected by changes in our genes, which could lead to better treatments for patients like you.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionDana-Farber Cancer Inst
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 1, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$65,869
NIH project number1P01CA295524-01
Project IDNIH-11016328 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with neuroendocrine cancers, particularly those affecting the prostate, lung, intestine, or skin.

Less likely to help

Patients with non-neuroendocrine cancers or those not affected by epigenetic changes may not receive any benefit from this research.

What this research studies

This research focuses on the administrative support for a program investigating neuroendocrine cancers, which include cancers from prostate, lung, intestine, and skin tissues. The Administrative Core will ensure effective collaboration among various projects and facilitate communication among researchers. By managing logistics, financial accounting, and coordinating meetings, the Core aims to enhance the overall understanding of how epigenetic mechanisms influence these cancers. Patients may benefit indirectly through improved research outcomes and advancements in treatment strategies.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for patients with neuroendocrine cancers.

How similar studies have gone: Previous research has shown promising results in understanding epigenetic changes in various cancers, indicating that this approach has potential for success.

Where this research is happening

  • Dana-Farber Cancer Inst
    Boston, United States
    Active

Researchers

  • Principal investigator: Decaprio, James a. — Dana-Farber Cancer Inst
  • Study coordinator: Decaprio, James a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.